Prolonged VV ECMO (265 Days) for ARDS without Technical Complications

ASAIO Journal

Volumn 61, Issue 2, 2015, Pages 205-206

  Wiktor, Arek J ^a   Haft, Jonathan W ^a   Bartlett, Robert H ^a   Park, Pauline K ^a   Raghavendran, Krishnan ^a   Napolitano, Lena M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

acute respiratory distress syndrome; circuit exchange; extracorporeal membrane oxygenation; futility; lung recovery; prolonged

Indexed keywords

BIOLOGICAL ORGANS; DIAGNOSIS;

ACUTE RESPIRATORY DISTRESS SYNDROME; CRITICAL CARE; DIAGNOSTIC MODALITY; LUNG TRANSPLANTATION; OBJECTIVE ASSESSMENT; TREATMENT MODALITY;

PATIENT REHABILITATION;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL GAS; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOPLEURAL FISTULA; CARDIOPULMONARY BYPASS CANNULA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HUMAN; HYPERCAPNIA; HYPOXEMIA; INTENSIVE CARE; LIMB SWELLING; LUNG BIOPSY; LUNG TRANSPLANTATION; MIDDLE AGED; MYALGIA; PRIORITY JOURNAL; PULMONARY ARTERY CATHETERIZATION; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; THORACOSCOPY; TREATMENT DURATION; TRICUSPID VALVE REGURGITATION; ADVERSE EFFECTS; COMPLICATION; FATALITY; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTOR;

ADULT; CRITICAL CARE; EXTRACORPOREAL MEMBRANE OXYGENATION; FATAL OUTCOME; FEMALE; HUMANS; HYPERCAPNIA; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTORS;

EID: 84937635788     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000181     Document Type: Article

References (11)

1. Pappalardo F, Pieri M, Greco T, Italian ECMOnet Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: The ECMOnet score. Intensive Care Med 2013 39 275 281
2. Teman NR, Haft JW, Napolitano LM, Optimal endovascular methods for placement of bicaval dual-lumen cannulae for venovenous extracorporeal membrane oxygenation. ASAIO J 2013 59 442 447
3. Diaz-Guzman E, Hoopes CW, Zwischenberger JB, The evolution of extracorporeal life support as a bridge to lung transplantation. ASAIO J 2013 59 3 10
4. Venado A, Hoopes CW, Diaz-Guzman E, Prolonged extracorporeal membrane oxygenation use as a bridge to lung transplantation: It is time for a national registry. Chest 2014 145 184 185
5. Snyder LD, Gray AL, Reynolds JM, Antibody desensitization therapy in highly sensitized lung transplant candidates. Am J Transplant 2014 14 849 856
6. Bartlett RH, Gattinoni L, Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 2010 76 534 540
7. Morris PE, Griffin L, Berry M, Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure. Am J Med Sci 2011 341 373 377
8. Abrams D, Javidfar J, Farrand E, Early mobilization of patients receiving extracorporeal membrane oxygenation: A retrospective cohort study. Crit Care 2014 18 R38
9. Rosenberg AA, Haft JW, Bartlett R, Prolonged duration ECMO for ARDS: Futility, native lung recovery, or transplantation? ASAIO J 2013 59 642 650
10. Gupta DK, Skali H, Rivero J, Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device. J Heart Lung Transplant 2014 33 372 381
11. Birks EJ, Molecular changes after left ventricular assist device support for heart failure. Circ Res 2013 113 777 791